Weiwei J. Sui
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 119 publications
Circulating tumor cells identify a disseminated genomic high-risk phenotype within IMS-IMWG 2025 staging in newly diagnosed multiple myeloma.
Journal: Leukemia
Published: June 09, 2026
Two Decades of Real-World Study in Newly Diagnosed Multiple Myeloma: Evolving Treatment and Outcomes in China with Reference to the United States.
Journal: Cancers
Published: October 23, 2025
Late and Durable Minimal Residual Disease Response Predicts Favorable Outcomes in Newly Diagnosed Multiple Myeloma.
Journal: International journal of cancer
Published: September 01, 2025
Prognostic significance of clinical risk models and genomic alterations in Waldenström macroglobulinemia before or after the BTK inhibitor era.
Journal: Leukemia
Published: August 10, 2025
Development of a Cytogenetic Double-Hit Model for Survival Prediction in Multiple Myeloma.
Journal: Cancers
Published: July 28, 2025
Long-term outcomes of CNCT19 chimeric antigen receptor T-cell therapy in relapsed or refractory aggressive B-cell lymphoma.
Journal: Chinese medical journal
Published: May 06, 2025
Long-term outcomes of CNCT19 chimeric antigen receptor T-cell therapy in relapsed or refractory aggressive B-cell lymphoma.
Journal: Chinese medical journal
Published: May 06, 2025
Identification of a CAR-Derived Clone by NGS-Based MRD After Fully Human BCMA CAR T-Cell Therapy in Multiple Myeloma.
Journal: American journal of hematology
Published: April 24, 2025
Correction: Targeting stem cell niche can protect hematopoietic stem cells from chemotherapy and G-CSF treatment.
Journal: Stem cell research & therapy
Published: April 17, 2025
Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma.
Journal: The Journal of clinical investigation
Published: March 17, 2025
Continuous R-DA-EDOCH alternated with high-dose Ara-C induces deep remission and overcomes high-risk factors in young patients with newly diagnosed mantle cell lymphoma.
Journal: Cancer biology & medicine
Published: March 12, 2025
Last Updated: 09/26/2026